Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

This is the first trial to prospectively demonstrate the impact of bone-protecting agents use on fracture risk for men receiving an androgen receptor pathway inhibitor.

Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...

Advanced stage prostate cancer often spreads to the bones, resulting in pain, fractures, and an increased risk of death. The outer layers of bones have nerves, and cancer that spreads to the leg ...

which reduces pain and fracture risk Improving progression-free survival and overall survival Reducing the risk of bone metastases from breast cancer and possibly prostate cancer by a third ...

Oct. 30, 2019 — About half of all women in the U.S. will suffer a bone fracture due to osteoporosis. For women, the incidence of this condition is greater than that of heart attack, stroke and breast ...

The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...